Please assess the completion status of the following clinical trial:

Trial Title: Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* PAOD (ABI \<0.90 and/or a decline of \>0.15 after exercise test), Rutherford category 2, 3 or 4~* Multiple (\>1) short (focal; \>1 and \< 5 cm) significant stenoses (≥ 50%) and/or occlusions in the superficial femoral artery~* Eligible for endovascular treatment via short spot stenting and via long lesion stenting according to international guidelines~* Unilateral occlusive disease~* Age ≥ 18~Exclusion Criteria:~* Patients with PAOD Rutherford category 5 and 6~* Impaired inflow due to significant lesions in the arteries proximal to the SFA intended to treat~* Bilateral lesions with treatment indication~* Contra-indication for anticoagulant therapy~* Renal insufficiency (MDRD \< 50 ml/min)~* Life expectancy \< 6 months~* Known contrast allergy~* Pregnancy~* Unable to complete a questionnaire in the home language

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Short spot stenting (Type: EXPERIMENTAL): Short spot stenting
- Long lesion stenting (Type: EXPERIMENTAL): Long lesion stenting

Based on this trial design, predict the completion outcome and termination type (if applicable).